The market for drugs to treat hepatitis C is expected to explode. Details, with Joshua Boger, Vertex Pharmaceuticals chairman/CEO & CNBC's Mike Huckman
Topics:
Economy (U.S.) | PharmaceuticalsHealth Care
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT